Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial
Agios Pharmaceuticals, Inc.
Ali T Taher; Hanny Al-Samkari; Yesim Aydinok; Martin Besser; Audra N Boscoe; Jayme L Dahlin; Gonzalo De Luna; Jeremie H Estepp; Sarah Gheuens; Keely S Gilroy; Andreas Glenthøj; Ai Sim Goh; Varsha Iyer; Antonis Kattamis; Sandra R Loggetto; Susan Morris; Khaled M Musallam; Kareem Osman; Paolo Ricchi; Eduardo Salido-Fiérrez; Sujit Sheth; Feng Tai; Heather Tevich; Katrin Uhlig; Rolandas Urbstonaitis; Vip Viprakasit; Maria Domenica Cappellini; Kevin H M Kuo; ENERGIZE investigators